Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Clinical Research/R&D

  • your selections
Clear Search

Filter Results

date

Tags

  • results
The Henry J. Kaiser Family Foundation

Public, Private Entities Continue Efforts To Develop Ebola Vaccines, Therapies

Media outlets report on various aspects of efforts to develop a vaccine for Ebola and produce more doses of experimental drugs to treat the disease. ABC News: Will There Be an Ebola Vaccine Soon? (Besser, 10/17). Agence France-Presse: Experimental Ebola vaccine expected in Geneva Tuesday: hospital (10/19). Agence France-Presse: Ebola…

News Summary Read More
The Henry J. Kaiser Family Foundation

U.S. Government Temporarily Suspends New Funding For ‘Gain-Of-Function’ Research On Infectious Diseases

News outlets report on a White House decision to temporarily cease new funding for gain-of-function research on certain infectious diseases. Nature News Blog: White House suspends enhanced pathogen research “As the U.S. public frets about the recent transmission of Ebola to two Texas health care workers, the U.S. government has…

News Summary Read More
The Henry J. Kaiser Family Foundation

News Outlets Examine Development, Importance Of Ebola Vaccines

News outlets report on efforts to develop an Ebola vaccine and the importance of using such a tool. The Guardian: Ebola epidemic may not end without developing vaccine, scientist warns (Boseley, 10/16). The Hill: HHS advances third Ebola vaccine development (Kamisar, 10/16). ScienceInsider: Issues continue to dog the testing of…

News Summary Read More
The Henry J. Kaiser Family Foundation

China Sends Experimental Ebola Drug To Africa For Clinical Trials

News outlets report that China has sent an experimental drug developed by its military to Africa for clinical trials. Financial Times: China sends thousands of doses of anti-Ebola drug to Africa “China has sent thousands of doses of an experimental anti-Ebola drug developed by the Chinese military to Africa. The…

News Summary Read More
The Henry J. Kaiser Family Foundation

Blocking Transmission Key In Malaria Fight

Devex: Block transmission Martin Edlund, CEO of Malaria No More “…[F]or malaria, the transit between mosquito and man isn’t just a joyride — it’s an essential step in reproduction. By blocking transmission, you isolate the mosquito and interrupt that process. … The classic approach to blocking transmission is to protect…

News Summary Read More
The Henry J. Kaiser Family Foundation

Research Continues To Develop Safe, Effective Ebola Vaccine

Media sources report on efforts to develop a vaccine to treat or prevent Ebola. CIDRAP News: At symposium, vaccine seen as best hope for arresting Ebola “At a wide-ranging symposium on West Africa’s Ebola epidemic [Tuesday], much of the attention focused on the hope of an effective vaccine, as a…

News Summary Read More
The Henry J. Kaiser Family Foundation

Investigational Rotavirus Vaccine In Late-Stage Clinical Trials

Reuters: Sanofi’s Rotavirus vaccine enters late-stage trials “French drugmaker Sanofi said on Tuesday an investigational vaccine designed by its Shantha Biotechnics unit to protect young children from severe diarrhea had entered late-stage clinical trials in India. The vaccine is aimed at rotavirus infections which cause gastroenteritis…” (Callus, 10/14).

News Summary Read More
The Henry J. Kaiser Family Foundation

Researchers Target Mosquitoes In Fight Against Malaria

National Geographic: The War on Bugs “Faced with more than 600,000 deaths a year from malaria, scientists and their philanthropic backers have set their sights on the lowly mosquito. If we could annihilate mosquitoes, malaria would go, too, and with it dengue and other plagues. But simple extermination by DEET…

News Summary Read More
The Henry J. Kaiser Family Foundation

Canadian Ebola Vaccine Begins Human Trials

News outlets report on the start of clinical trials testing a Canadian Ebola vaccine. Agence France-Presse: Experimental Canadian Ebola vaccine starts human tests (10/13). Globe and Mail: As vaccine trials begin, Canada set to review Ebola strategy (Wingrove, 10/14). Reuters: Human testing begins on NewLink Genetics’ Ebola vaccine (Grover, 10/13).…

News Summary Read More
The Henry J. Kaiser Family Foundation

U.S. Officials Comment On Dallas Ebola Cases, Research Into Vaccines

News outlets report on U.S. health officials’ statements about the U.S. Ebola cases and research for a vaccine. Agence France-Presse: First U.S. Ebola infection result of ‘protocol breach’ “A Texas health care worker has become the first person to contract Ebola on American soil, authorities confirmed, blaming a safety breach…

News Summary Read More